Perfil
Jayne M.
Gansler served as Senior Vice President of Human Resources at ARIAD Pharmaceuticals, Inc. She also held the position of Senior Vice President of Global Human Resources at Genzyme Corp.
from 2002 to 2011.
Recently, she served as Chief People Officer and Executive Vice President at Seres Therapeutics, Inc. from 2020 to 2022.
Gansler received her undergraduate degree from the University of Massachusetts.
Antiguos cargos conocidos de Jayne M. Gansler.
| Empresas | Cargo | Fin |
|---|---|---|
| SERES THERAPEUTICS, INC. | Oficial de Recursos Humanos | 07/02/2022 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Oficial de Recursos Humanos | 01/01/2011 |
| ARIAD PHARMACEUTICALS, INC. | Oficial de Recursos Humanos | - |
Formación de Jayne M. Gansler.
| University of Massachusetts | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SERES THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jayne M. Gansler
